Clinical trial management systems (ctms) market forecast to 2022

Clinical Trial Management Systems (CTMS) Market, by Components, (Software, Service), Delivery Mode (Web-based, Onsite, Cloud-based) End-users (Pharmaceutical and Biotechnology Companies, Contract Research Organizations, Medical Device Companies), – Global Revenue, Trends, Growth, Share, Size and Forecast to 2022

December 2016

1

About Scalar Market Research Scalar Market Research, Inc. is a Chicago, U.S. based market research and consulting firm that serves Fortune 1000 companies, leading businesses, and upcoming organizations from around the world to help them achieve their business goal of sustainable revenue growth, utilizing Scalar's premium market research reports and consulting services to make critical strategic decisions.

Our real-time industry data tracking, with the help of advanced analytics and machine learning, offers our clients highly accurate 360-degree perspective of key developments in niche markets. Our team of industry experts, with a thorough understanding of global markets and cumulative industry experience spanning 100+

E

years, work relentlessly to help our clients realize their most important business

PL

goals.

M

Terms of Use

This report bears a contractual agreement between Scalar Market Research and the

SA

buyer. No part of the content of this report can be shared or published to other individuals, companies, subsidiaries, divisions, or subdivisions of any organization.

The redistribution of the report in any manner is strictly prohibited without the prior permission of Scalar Market Research. The publisher will, in turn, regard the privacy of the purchaser, and will keep it confidential. This report is informative material and is not meant for managerial, legal or accounting advice. This publication in no case should be used as an endorsement of any product, a corporate guide or, business manual.

Copyright Š 2016 Scalar Market Research, Inc., USA All Rights Reserved. This document enclosing highly confidential information is the sole property of Scalar Market Research. No part of this document shall be reproduced, copied, quoted, circulated, or otherwise shared without prior approval of Scalar Market Research.

2

Table of Contents MARKET OVERVIEW ......................................................................................................................16 1.1

Definitions.............................................................................................................................16

1.2

Research Methodology .........................................................................................................16 Primary Data .................................................................................................................17

1.2.2

Secondary Data .............................................................................................................17

1.2.3

Machine Learning..........................................................................................................18

1.2.4

Research Scope .............................................................................................................18

1.2.5

Years Considered ..........................................................................................................20

1.2.6

Currency & Pricing.........................................................................................................21

E

1.2.1

Market Segmentation ...........................................................................................................21

1.4

Key Objectives & Benefits of the Report...............................................................................23

PL

1.3

1.4.1

Objectives of the Report ...............................................................................................23

1.4.2

Key Benefits of the Report ............................................................................................23

M

1

EXECUTIVE SUMMARY ..................................................................................................................24

3

MARKET DYNAMICS ......................................................................................................................26 3.1

Drivers ...................................................................................................................................26

3.2

Restraints ..............................................................................................................................27

3.3

Opportunities........................................................................................................................28

3.3.1

Increasing global geriatric population ..........................................................................28

3.3.2

High prevalence rate of chronic diseases .....................................................................28

3.3.3

Increased Healthcare Awareness..................................................................................29

3.4

4

SA

2

Premium Industry Trends .....................................................................................................30

3.4.1

Rising healthcare expenditures across the world .........................................................30

3.4.2

Increased outsourcing of clinical research activities ....................................................30

3.4.3

Globalization of clinical trials ........................................................................................30

INDUSTRY ANALYSIS......................................................................................................................31 4.1

Supply Chain Analysis............................................................................................................31

4.2

Ecosystem Analysis ...............................................................................................................32

3

5

CLINICAL TRIAL MANAGEMENT SYSTEMS (CTMS) MARKET, BY COMPONENTS...........................33 5.1.1 Global Clinical trial management systems (CTMS) Market Share (%), By Components, 2016 & 2022..................................................................................................................................33 5.1.2 Global Clinical Trial Management Systems (CTMS) Market Size (US$ billion), By Components (2014 – 2022)...........................................................................................................34 5.1.3 Global Clinical Trial Management Systems (CTMS) Market Size (US$ billion), By Components, 2016 & 2022 ...........................................................................................................35 5.2

Software................................................................................................................................36

5.2.1 Global Clinical Trial Management Systems (CTMS) Software Market Size (US$ billion),

By Regions (2014 – 2022)..............................................................................................................36 5.3

Service...................................................................................................................................37

5.3.1 Global Clinical Trial Management Systems (CTMS) Service Market Size (US$ billion), By Regions (2014 – 2022)...................................................................................................................37 CLINICAL TRIAL MANAGEMENT SYSTEMS (CTMS) MARKET, BY END-USERS................................38

E

6

PL

6.1.1 Global Clinical Trial Management Systems (CTMS) Market Share (%), By End-users, 2016 & 2022..................................................................................................................................39 6.1.2 Global Clinical Trial Management Systems (CTMS) Market Size (US$ billion), By Endusers (2014 – 2022).......................................................................................................................39

Pharmaceutical and Biotechnology Companies ...................................................................41

SA

6.2

M

6.1.3 Global Clinical Trial Management Systems (CTMS) Market Size (US$ billion), By Endusers, 2016 & 2022 .......................................................................................................................40

6.2.1 Global Clinical Trial Management Systems (CTMS) Market Size (US$ billion) in Pharmaceutical and Biotechnology, By Regions (2014 – 2022)....................................................41 6.3

Clinical Research Organizations (CROs) ................................................................................41

6.3.1 Global Clinical Trial Management Systems (CTMS) Market Size (US$ billion) in Clinical Research Organizations (CROs), By Regions (2014 – 2022) ..........................................................41 6.4

Medical Device Companies ...................................................................................................42

6.4.1 Global Clinical Trial Management Systems (CTMS) Market Size (US$ billion) in Medical Device Companies, By Regions (2014 – 2022) ..............................................................................42 7

CLINICAL TRIAL MANAGEMENT SYSTEMS (CTMS) MARKET, BY DELIVERY MODES......................43 7.1.1 Global Clinical Trial Management Systems (CTMS) Market Share (%), By Delivery Mode, 2016 & 2022 ......................................................................................................................44 7.1.2 Global Clinical Trial Management Systems (CTMS) Market Size (US$ billion), By Delivery Mode (2014 – 2022) .......................................................................................................44 7.1.3 Global Clinical Trial Management Systems (CTMS) Market Size (US$ billion), By Delivery Mode, 2016 & 2022 ........................................................................................................45

4

7.2

Web-Based Delivery Mode ...................................................................................................46

7.2.1 Global Clinical Trial Management Systems (CTMS) Market Size (US$ billion) in Webbased Delivery Mode, By Regions (2014 – 2022) .........................................................................46 7.3

On-Site Delivery Mode..........................................................................................................47

7.3.1 Global Clinical Trial Management Systems (CTMS) Market Size (US$ billion) in On-Site Delivery Mode, By Regions (2014 – 2022) ....................................................................................47 7.4

Cloud-Based Delivery Mode..................................................................................................47

7.4.1 Global Clinical Trial Management Systems (CTMS) Market Size (US$ billion) in Cloudbased Delivery Mode, By Regions (2014 – 2022) .........................................................................47 CLINICAL TRIAL MANAGEMENT SYSTEMS (CTMS) MARKET, BY REGIONS....................................48 8.1

Segment Share ......................................................................................................................49

8.1.1 Global Clinical Trial Management Systems (CTMS) Market Size (US$ billion), By Regions (2014 – 2022)...................................................................................................................49

North America.......................................................................................................................51

PL

8.2

E

8.1.2 Global Clinical Trial Management Systems (CTMS) Market Size (US$ billion), By Regions, 2016 & 2022 ...................................................................................................................50

8.2.1 North America Clinical Trial Management Systems (CTMS) Market Share (%), By Country, 2016 & 2022 ...................................................................................................................51

M

8.2.2 North America Clinical Trial Management Systems (CTMS) Market Size (US$ billion),

By Country (2014 – 2022) .............................................................................................................52 8.2.3 North America Clinical Trial Management Systems (CTMS) Market Size (US$ billion),

By Country, 2016 & 2022 ..............................................................................................................52 8.2.3.1

SA

8

U.S. ............................................................................................................................53

8.2.3.1.1 Clinical Trial Management Systems (CTMS) Market in U.S., Market Size (US$ billion) and Y-o-Y Growth (%)................................................................................................53 8.2.3.2

Rest of North America...............................................................................................53

8.2.3.2.1 Clinical Trial Management Systems (CTMS) Market in Rest of North America, Market Size (US$ billion) and Y-o-Y Growth (%) ...................................................................53 8.2.4 North America Clinical Trial Management Systems (CTMS) Market Size (US$ billion),

By Components (2014 – 2022)......................................................................................................54 8.2.5 North America Clinical Trial Management Systems (CTMS) Market Size (US$ billion),

By End-users (2014 – 2022) ..........................................................................................................54 8.2.6 North America Clinical Trial Management Systems (CTMS) Market Size (US$ billion),

By Delivery Mode (2014 – 2022)...................................................................................................55 8.3

Europe...................................................................................................................................56

5

8.3.1 Europe Clinical Trial Management Systems (CTMS) Market Share (%), By Country, 2016 & 2022..................................................................................................................................56 8.3.2 Europe Clinical Trial Management Systems (CTMS) Market Size (US$ billion), By Country (2014 – 2022) ..................................................................................................................57 8.3.3 Europe Clinical Trial Management Systems (CTMS) Market Size (US$ billion), By Country, 2016 & 2022 ...................................................................................................................57 8.3.3.1

France........................................................................................................................58

8.3.3.1.1 Clinical Trial Management Systems (CTMS) Market in France, Market Size (US$ billion) and Y-o-Y Growth (%)................................................................................................58 8.3.3.2

Germany....................................................................................................................58

8.3.3.2.1 Clinical Trial Management Systems (CTMS) Market in Germany, Market Size (US$ billion) and Y-o-Y Growth (%) .......................................................................................58 8.3.3.3

U.K.............................................................................................................................59

Rest of Europe...........................................................................................................59

PL

8.3.3.4

E

8.3.3.3.1 Clinical Trial Management Systems (CTMS) Market in U.K, Market Size (US$ billion) and Y-o-Y Growth (%)................................................................................................59

8.3.3.4.1 Clinical Trial Management Systems (CTMS) Market in Rest of Europe, Market Size (US$ billion) and Y-o-Y Growth (%) ................................................................................59

M

8.3.4 Europe Clinical Trial Management Systems (CTMS) Market Size (US$ billion), By Components (2014 – 2022)...........................................................................................................59

SA

8.3.5 Europe Clinical Trial Management Systems (CTMS) Market Size (US$ billion), By Endusers (2014 – 2022).......................................................................................................................60 8.3.6 Europe Clinical Trial Management Systems (CTMS) Market Size (US$ billion), By Delivery Mode (2014 – 2022) .......................................................................................................60 8.4

Asia-Pacific ............................................................................................................................61

8.4.1 Asia-Pacific Clinical Trial Management Systems (CTMS) Market Share (%), By Country, 2016 & 2022..................................................................................................................................61 8.4.2 Asia-Pacific Clinical Trial Management Systems (CTMS) Market Size (US$ billion), By Country (2014 – 2022) ..................................................................................................................62 8.4.3 Asia-Pacific Clinical Trial Management Systems (CTMS) Market Size (US$ billion), By Country, 2016 & 2022 ...................................................................................................................63 8.4.3.1

China .........................................................................................................................63

8.4.3.1.1 Clinical Trial Management Systems (CTMS) Market in China, Market Size (US$ billion) and Y-o-Y Growth (%)................................................................................................63 8.4.3.2

India...........................................................................................................................64

6

8.4.3.2.1 Clinical Trial Management Systems (CTMS) Market in India, Market Size (US$ billion) and Y-o-Y Growth (%)................................................................................................64 8.4.3.3

Japan .........................................................................................................................64

8.4.3.3.1 Clinical Trial Management Systems (CTMS) Market in Japan, Market Size (US$ billion) and Y-o-Y Growth (%)................................................................................................64 8.4.3.4

Rest of Asia-Pacific ....................................................................................................64

8.4.3.4.1 Clinical Trial Management Systems (CTMS) Market in Rest of Asia-Pacific, Market Size (US$ billion) and Y-o-Y Growth (%) ...................................................................64 8.4.4 Asia-Pacific Clinical Trial Management Systems (CTMS) Market Size (US$ billion), By Components (2014 – 2022)...........................................................................................................65 8.4.5 Asia-Pacific Clinical Trial Management Systems (CTMS) Market Size (US$ billion), By End-users (2014 – 2022) ...............................................................................................................65 8.4.6 Asia-Pacific Clinical Trial Management Systems (CTMS) Market Size (US$ billion), By Delivery Mode (2014 – 2022) .......................................................................................................66

8.5.1 & 2022

E

Rest of the World (RoW).......................................................................................................67 RoW Clinical Trial Management Systems (CTMS) Market Share (%), By Country, 2016 67

PL

8.5

8.5.2 RoW Clinical Trial Management Systems (CTMS) Market Size (US$ billion), By Country (2014 – 2022) ................................................................................................................................68

Latin America ............................................................................................................69

SA

8.5.3.1

M

8.5.3 RoW Clinical Trial Management Systems (CTMS) Market Size (US$ billion), By Country, 2016 & 2022..................................................................................................................................68

8.5.3.1.1 Clinical Trial Management Systems (CTMS) Market in Latin America, Market Size (US$ billion) and Y-o-Y Growth (%) ................................................................................69 8.5.3.2

Middle East and Africa ..............................................................................................69

8.5.3.2.1 Clinical Trial Management Systems (CTMS) Market in Middle East and Africa, Market Size (US$ billion) and Y-o-Y Growth (%) ...................................................................69 8.5.4 Rest of the World Clinical Trial Management Systems (CTMS) Market Size (US$ billion), By Components (2014 – 2022).........................................................................................70 8.5.5 Rest of the World Clinical Trial Management Systems (CTMS) Market Size (US$ billion), By End-users (2014 – 2022) .............................................................................................70 8.5.6 Rest of the World Clinical Trial Management Systems (CTMS) Market Size (US$ billion), By Delivery Mode (2014 – 2022)......................................................................................71 9

COMPETITIVE LANDSCAPE ............................................................................................................72 9.1

Market Positioning of Key Players ........................................................................................72

10 KEY MARKET PLAYERS ...................................................................................................................73

7

10.1.1

Medidata Solutions, Inc. ...............................................................................................73

10.1.2

Overview .......................................................................................................................73

10.1.3

Key Strategies................................................................................................................73

10.1.3.1

Focus on Product Innovation ................................................................................73

10.1.3.2

Strategic Acquisitions and Partnerships to Strengthen Technological Capabilities 73

10.1.4 10.2

Recent Developments...................................................................................................73

PAREXEL International Corporation......................................................................................75

10.2.1

Overview .......................................................................................................................75

10.2.2

Key Strategies................................................................................................................75 Strategic Acquisitions and Partnerships to Strengthen Client Base .....................75

10.2.2.2

Innovative Product Development .........................................................................75

10.2.2.3

Market Expansion .................................................................................................75

10.3

Recent Developments...................................................................................................75

PL

10.2.3

E

10.2.2.1

Bioclinica. ..............................................................................................................................77 Overview .......................................................................................................................77

10.3.2

Key Strategies................................................................................................................77 Strategic Acquisitions, Collaborations and Partnerships ......................................77

10.3.2.2

New Product Development...................................................................................77

SA

10.3.2.1

10.3.3 10.4

M

10.3.1

Recent Developments...................................................................................................77

Bio-Optronics, Inc..................................................................................................................79

10.4.1

Overview .......................................................................................................................79

10.4.2

Key Strategies................................................................................................................79

10.4.2.1 10.4.3 10.5

Strategic Acquisitions and Collaborations ............................................................79

Recent Developments...................................................................................................79

ERT Clinical. ...........................................................................................................................80

10.5.1

Overview .......................................................................................................................80

10.5.2

Key Strategies................................................................................................................80

10.5.2.1

Product Development ...........................................................................................80

10.5.2.2

Strategic Market Expansion ..................................................................................80

10.5.2.3

Strategic Acquisitions to Expand their Capabilities...............................................80

8

10.5.3 10.6

Recent Development ....................................................................................................80

DATATRAK International, Inc. ...............................................................................................82

10.6.1

Overview .......................................................................................................................82

10.6.2

Key Strategies................................................................................................................82

10.6.2.1

Product Innovation ...............................................................................................82

10.6.2.2

Strategic Acquisitions, Collaborations and Partnerships ......................................82

10.6.3 10.7

Recent Developments...................................................................................................82

MedNet Solutions, Inc...........................................................................................................84

10.7.1

Overview .......................................................................................................................84

10.7.2

Key Strategies................................................................................................................84

10.7.2.1

10.8

Recent Developments...................................................................................................84

E

10.7.3

Strategic Acquisitions, Collaborations and Partnerships ......................................84

Forte Research Systems, Inc. ................................................................................................85 Overview .......................................................................................................................85

10.8.2

Key Strategies................................................................................................................85

10.8.2.1

10.9

Strategic Collaborations and Partnerships............................................................85

Recent Developments...................................................................................................85

M

10.8.3

PL

10.8.1

Merge Healthcare Incorporated. ..........................................................................................86 Overview .......................................................................................................................86

10.9.2

Key Strategies................................................................................................................86

10.9.2.1 10.9.3

SA

10.9.1

Focus on Strategic Acquisitions, Collaborations and Partnerships.......................86

Recent Developments...................................................................................................86

10.10 Veeva Systems ......................................................................................................................88 10.10.1

Overview ...................................................................................................................88

10.10.2

Key Strategies............................................................................................................88

10.10.2.1

Focus on Market Expansion ..................................................................................88

10.10.2.2 88

Strategic Acquisitions and Partnerships to Strengthen Technological Capabilities..

10.10.3

Recent Developments...............................................................................................88

10.11 DSG, Inc. ................................................................................................................................90 10.11.1

Overview ...................................................................................................................90

9

10.11.2 10.11.2.1 90 10.11.3

Key Strategies............................................................................................................90 Strategic Acquisitions and Partnerships to Strengthen Technological Capabilities..

Recent Developments...............................................................................................90

11 SCALAR 360 DEGREE MARKET PERSPECTIVE ................................................................................91 12 APPENDIX ......................................................................................................................................93 Acronyms ..............................................................................................................................93

12.2

Related Reports.....................................................................................................................94

SA

M

PL

E

12.1

10

List of Tables Table 1.

Primary Data .....................................................................................................................17

Table 2.

Primary Sources ................................................................................................................17

Table 3.

Secondary Data .................................................................................................................17

Table 4.

Advantages of Machine Learning-based Forecasts ..........................................................18

Table 5.

Years Considered ..............................................................................................................20

Table 6.

Global Clinical Trial Management Systems (CTMS) Market Snapshot..............................25

Table 7.

Global Clinical Trial Management Systems (CTMS) Market Drivers .................................26

Table 8.

Global Clinical Trial Management Systems (CTMS) Market Restraints ............................27

E

Table 9.

Global Clinical Trial Management Systems (CTMS) Market Size (US$ billion), By Components (2014 – 2022) ..................................................................................................................34

PL

Table 10. Global Clinical Trial Management Systems (CTMS) Software Market Size (US$ billion), By Regions (2014 – 2022) ..........................................................................................................................36 Table 11. Global Clinical Trial Management Systems (CTMS) Service Market Size (US$ billion), By Regions (2014 – 2022) ..........................................................................................................................37

M

Table 12. Global Clinical Trial Management Systems (CTMS) Market Size (US$ billion), By End-users (2014 – 2022) ........................................................................................................................................39

SA

Table 13. Global Clinical Trial Management Systems (CTMS) Market Size (US$ billion) in Pharmaceutical and Biotechnology, By Regions (2014 – 2022)............................................................41 Table 14. Global Clinical Trial Management Systems (CTMS) Market Size (US$ billion) in Clinical Research Organizations (CROs), By Regions (2014 – 2022)..................................................................41 Table 15. Global Clinical Trial Management Systems (CTMS) Market Size (US$ billion) in Medical Device Companies, By Regions (2014 – 2022) ......................................................................................42 Table 16. Global Clinical Trial Management Systems (CTMS) Market Size (US$ billion), By Delivery Mode (2014 – 2022)..............................................................................................................................44 Table 17. Global Clinical Trial Management Systems (CTMS) Market Size (US$ billion) in Webbased Delivery Mode, By Regions (2014 – 2022) .................................................................................46 Table 18. Global Clinical Trial Management Systems (CTMS) Market Size (US$ billion) in On-Site Delivery Mode, By Regions (2014 – 2022) ............................................................................................47 Table 19. Global Clinical Trial Management Systems (CTMS) Market Size (US$ billion) in Cloudbased Delivery Mode, By Regions (2014 – 2022) .................................................................................47 Table 20. Global Clinical Trial Management Systems (CTMS) Market Size (US$ billion), By Regions (2014 – 2022) ........................................................................................................................................49

11

Table 21. North America Clinical Trial Management Systems (CTMS) Market Size (US$ billion), By Country (2014 – 2022) ..........................................................................................................................52 Table 22. 8.2.3.1.1 Clinical Trial Management Systems (CTMS) Market in U.S., Market Size (US$ billion) and Y-o-Y Growth (%)................................................................................................................53 Table 23. Clinical Trial Management Systems (CTMS) Market in Rest of North America, Market Size (US$ billion) and Y-o-Y Growth (%) .......................................................................................................53 Table 24. North America Clinical Trial Management Systems (CTMS) Market Size (US$ billion), By Components (2014 – 2022) ..................................................................................................................54 Table 25. North America Clinical Trial Management Systems (CTMS) Market Size (US$ billion), By End-users (2014 – 2022) .......................................................................................................................54 Table 26. North America Clinical Trial Management Systems (CTMS) Market Size (US$ billion), By Delivery Mode (2014 – 2022) ...............................................................................................................55 Table 27. Europe Clinical Trial Management Systems (CTMS) Market Size (US$ billion), By Country (2014 – 2022) ........................................................................................................................................57

E

Table 28. Clinical Trial Management Systems (CTMS) Market in France, Market Size (US$ billion) and Y-o-Y Growth (%)............................................................................................................................58

PL

Table 29. Clinical Trial Management Systems (CTMS) Market in Germany, Market Size (US$ billion) and Y-o-Y Growth (%)............................................................................................................................58

M

Table 30. Clinical Trial Management Systems (CTMS) Market in U.K, Market Size (US$ billion) and Y-o-Y Growth (%)...................................................................................................................................59

SA

Table 31. Clinical Trial Management Systems (CTMS) Market in Rest of Europe, Market Size (US$ billion) and Y-o-Y Growth (%)................................................................................................................59 Table 32. Europe Clinical Trial Management Systems (CTMS) Market Size (US$ billion), By Components (2014 – 2022) ..................................................................................................................59 Table 33. Europe Clinical Trial Management Systems (CTMS) Market Size (US$ billion), By Endusers (2014 – 2022)...............................................................................................................................60 Table 34. Europe Clinical Trial Management Systems (CTMS) Market Size (US$ billion), By Delivery Mode (2014 – 2022)..............................................................................................................................60 Table 35. Asia-Pacific Clinical Trial Management Systems (CTMS) Market Size (US$ billion), By Country (2014 – 2022) ..........................................................................................................................62 Table 36. Clinical Trial Management Systems (CTMS) Market in China, Market Size (US$ billion) and Y-o-Y Growth (%)............................................................................................................................63 Table 37. Clinical Trial Management Systems (CTMS) Market in India, Market Size (US$ billion) and Y-o-Y Growth (%)...................................................................................................................................64 Table 38. Clinical Trial Management Systems (CTMS) Market in Japan, Market Size (US$ billion) and Y-o-Y Growth (%)............................................................................................................................64 Table 39. Clinical Trial Management Systems (CTMS) Market in Rest of Asia-Pacific, Market Size (US$ billion) and Y-o-Y Growth (%) .......................................................................................................64

12

Table 40. Asia-Pacific Clinical Trial Management Systems (CTMS) Market Size (US$ billion), By Components (2014 – 2022) ..................................................................................................................65 Table 41. Asia-Pacific Clinical Trial Management Systems (CTMS) Market Size (US$ billion), By Endusers (2014 – 2022)...............................................................................................................................65 Table 42. Asia-Pacific Clinical Trial Management Systems (CTMS) Market Size (US$ billion), By Delivery Mode (2014 – 2022) ...............................................................................................................66 Table 43. RoW Clinical Trial Management Systems (CTMS) Market Size (US$ billion), By Country (2014 – 2022) ........................................................................................................................................68 Table 44. Clinical Trial Management Systems (CTMS) Market in Latin America, Market Size (US$ billion) and Y-o-Y Growth (%)................................................................................................................69 Table 45. Clinical Trial Management Systems (CTMS) Market in Middle East and Africa, Market Size (US$ billion) and Y-o-Y Growth (%)................................................................................................69 Table 46. Rest of the World Clinical Trial Management Systems (CTMS) Market Size (US$ billion),

By Components (2014 – 2022)..............................................................................................................70

E

Table 47. Rest of the World Clinical Trial Management Systems (CTMS) Market Size (US$ billion),

By End-users (2014 – 2022) ..................................................................................................................70

PL

Table 48. Rest of the World Clinical Trial Management Systems (CTMS) Market Size (US$ billion),

By Delivery Mode (2014 – 2022)...........................................................................................................71 Clinical Trial Management Systems (CTMS) Market Snapshot .........................................92

Table 50.

List of Acronyms................................................................................................................93

SA

M

Table 49.

13

List of Figures Figure 1.

Research Methodology .....................................................................................................20

Figure 2.

Global Clinical Trial Management Systems (CTMS) Market, By Components ..................21

Figure 3.

Global Clinical Trial Management Systems (CTMS) Market, By Delivery Modes .............21

Figure 4.

Global Clinical Trial Management Systems (CTMS) Market, By End-Users ......................22

Figure 5.

Global Clinical Trial Management Systems (CTMS) Market, By Regions ..........................22

Figure 6.

Clinical Trial Management Systems (CTMS) Market – IoT Enabled Supply Chain Analysis 31

Figure 7.

Clinical Trial Management Systems (CTMS) Market – Functional Process Map...............32

E

Figure 8. Global Clinical trial management systems (CTMS) Market Share (%), By Components, 2016 & 2022..........................................................................................................................................33

PL

Figure 9. Global Clinical Trial Management Systems (CTMS) Market Size (US$ billion), By Components, 2016 & 2022 ...................................................................................................................35 Figure 10.

Global Clinical Trial Management Systems (CTMS) Market Share (%), By End-users, 2016 & 2022 39

M

Figure 11.

Global Clinical Trial Management Systems (CTMS) Market Size (US$ billion), By Endusers, 2016 & 2022 ...............................................................................................................................40

SA

Figure 12.

Global Clinical Trial Management Systems (CTMS) Market Share (%), By Delivery Mode, 2016 & 2022 ..............................................................................................................................44 Figure 13.

Global Clinical Trial Management Systems (CTMS) Market Size (US$ billion), By Delivery Mode, 2016 & 2022 ................................................................................................................45 Figure 14. and 2022

Global Clinical Trial Management Systems (CTMS) Market Share (%), By Regions, 2016 49

Figure 15.

Global Clinical Trial Management Systems (CTMS) Market Size (US$ billion), By Regions, 2016 & 2022 ...........................................................................................................................50 Figure 16.

North America Clinical Trial Management Systems (CTMS) Market Share (%), By Country, 2016 & 2022...........................................................................................................................51 Figure 17.

North America Clinical Trial Management Systems (CTMS) Market Size (US$ billion),

By Country, 2016 & 2022 ......................................................................................................................52 Figure 18.

Europe Clinical Trial Management Systems (CTMS) Market Share (%), By Country, 2016 & 2022 56 Figure 19.

Europe Clinical Trial Management Systems (CTMS) Market Size (US$ billion), By Country, 2016 & 2022...........................................................................................................................57

14

Figure 20.

Asia-Pacific Clinical Trial Management Systems (CTMS) Market Share (%), By Country, 2016 & 2022 61 Figure 21.

Asia-Pacific Clinical Trial Management Systems (CTMS) Market Size (US$ billion), By Country, 2016 & 2022...........................................................................................................................63 Figure 22. & 2022

RoW Clinical Trial Management Systems (CTMS) Market Share (%), By Country, 2016 67

Figure 23.

RoW Clinical Trial Management Systems (CTMS) Market Size (US$ billion), By Country, 2016 & 2022 68

M

PL

E

Market Positioning of Key Players ................................................................................72

SA

Figure 24.

15

1 MARKET OVERVIEW 1.1 Definitions There has been an increase in both the cost and complexity of conducting clinical trials that is in turn threatening the profit quotient of drug candidates and the economic feasibility of pharmaceutical drug discovery research. Thus, the industry is actively looking out to limit these costs, as both the governments and payers of healthcare are inclining towards lowering the cost of care provision and the manufacturing cost of pharmaceuticals. Furthermore, the development stage of the drug lifecycle is a potential source of competitive advantage and is being increasingly viewed by life sciences organizations. These firms are looking forward

E

to reducing the cycle times that drug candidates take to reach the market. Thus, the pharmaceutical manufacturers are increasingly outsourcing the management of

PL

clinical trials from third parties, thereby driving growth in the small and medium-sized companies of the clinical trial management systems (CTMS) market.

The ‘Clinical Trial Management Systems (CTMS) Market – Global Revenue,

M

Trends, Growth, Share, Size and Forecast to 2022' report includes market size

SA

and forecast estimates for the period 2014 to 2022. The scope of this report includes software and service components of clinically trial management systems, delivery modes such as web-based, on-site and cloud-based and their end-users such as pharmaceutical and biotechnology companies, contract research organizations and medical device companies. The report segments the market based on components, delivery modes, end-users, and regions. The report includes market size and forecast estimates for all market segments in the study period. The report has 2015 as the base year, 2014 as the historical year, and 2016 to 2022 as the forecast period.

1.2 Research Methodology We utilize a mix of primary research, secondary research, and machine learning algorithms to generate comprehensive data about market sizes and revenue forecasts. Our primary focus on continuous market tracking, rigorous fact-checking, data-triangulation, and multiple layers of quality control ensures high-quality data that can be leveraged for actionable research insights.

16

1.2.1 Primary Data Table 1.

Primary Data

Perspective

Primary Research    

Supply Side Demand Side

Software Developers Vendors End-users Consumers

Structured interviews with industry specialists, VPs, CEOs, directors, technology consultants were taken in order to collect the key primary data. The primary data is focused on both the demand and supply sides of the market. Market Engineering

E

has been carried out from the data and excessive analysis has been done on it.

Primary data is also extensively considered while validating the secondary data.

Primary Sources

PL

Table 2.

Primary Sources

       

SA

M

Report Parameters

Key Industry Participants (KPIs)

Vendors Government Agencies Regulatory Bodies Research & Development Companies Investment Research Companies Business Consulting Service Providers Academic Institutions/Universities Venture Capitalists

1.2.2 Secondary Data Table 3.

Secondary Data

Report Parameters Market Size, Revenue, Industry Analysis, Value Chain Analysis, Ecosystem Analysis, Premium Industry Trends, End-users

Perspective

Supply Side

17

Secondary Research      

Company Annual Reports SEC Filings Financial Journals Trade Journals Market Journals Press Releases

Analysis, Market Segmentation, Geographic Analysis, Key Market Players, Competitive Landscape

Demand Side

     

Directories White Papers Company Websites Magazines Case Studies Customer References

The data from important secondary sources is utilized to obtain industry supply chains, company profiles, and other key areas such as market drivers, opportunities, trends from the market perspective. In addition, secondary data is gathered using paid databases such as Bloomberg, Hoovers, Factiva, and government publishing sources.

E

1.2.3 Machine Learning In addition to assigning weights to all the relevant market parameters, to quantify

PL

their market impact for generating projected market growth rate, we use advanced machine learning algorithms to collate essential market data. The machine learning method utilizes algorithms such as regression, correlation, and decision tree, among

Table 4.

M

others, to derive the desired output.

Advantages of Machine Learning-based Forecasts

Advantages of Machine Learning-based Forecasts

SA

Perspective

Using Machine Learning for Data Forecast

     

Unlimited Data Highly Detailed Forecasts Profound Knowledge of Demand Broad Applicability Customizable Model Identifies Drivers Analysis - Product, Value Chain, Supply Chain, Competitor

1.2.4 Research Scope We have utilized the top-down, bottom-up approach to study the market size, industry dynamics, key regional markets, and major market trends. The global market has been estimated by integrating the regional markets, estimating the market data for the base year 2015, and annual share and revenue forecasts to 2022 in US$.

18

1.2.6 Currency & Pricing The currency used in the report is the U.S. dollar, with market size indicated in US$ million and US$ billion. 

Revenue is obtained from the annual company reports (For all the companies reporting their revenue in US$)



Revenue is converted as per the annual currency exchange rate for that particular year (For the companies reporting their revenue in currencies other than US$)

1.3 Market Segmentation

E

Figure 2. Global Clinical Trial Management Systems (CTMS) Market, By Components

M

PL

Clinical Trial Management Systems,

By Components Services

SA

Software Source: Scalar Market Research Analysis

Figure 3. Global Clinical Trial Management Systems (CTMS) Market, By Delivery Modes

Clinical Trial Management Systems,

By Delivery Modes Web-based

On-premises

Source: Scalar Market Research Analysis

21

Cloud-based

Figure 4. Global Clinical Trial Management Systems (CTMS) Market, By End-Users

Clinical Trial Management System,

By End-users Pharmaceutical & Biotechnology Companies

Clinical Research Organizations

Medical Device Companies

Source: Scalar Market Research Analysis

Figure 5. Global Clinical Trial Management Systems (CTMS) Market, By Regions

Europe

PL

North America

E

Clinical Trial Management System,

By Regions Asia Pacific

Rest of the World

China

Latin America

Germany

India

MEA

U.K

Japan

Rest of Europe

Rest of APAC

France

M

U.S.

SA

Rest of North America

Source: Scalar Market Research Analysis

22

2 EXECUTIVE SUMMARY The objective of this report is to describe the market trends and revenue forecasts for the Clinical Trial Management Systems (CTMS) market for the next six years.

The report focuses on defining and describing the key influencing factors for the growth of the market. It also offers an in-depth analysis of the market size (revenue), market share, major market segments, different geographic regions, key market players, and premium industry trends.

The report tracks the major market events including product launches, technological developments, mergers & acquisitions, and the innovative business strategies opted by key market players. Along with strategically analyzing the key micro-markets, the report also focuses on industry-specific drivers, restraints, and opportunities in the

E

Clinical Trial Management Systems (CTMS) market. The scope of this report covers

PL

the Clinical Trial Management Systems (CTMS) market by its major segments, which include the components, end-users, and the major geographic regions.

The key market players profiled in this report are Medidata Solutions, Inc., BioClinica

M

Inc., DATATRAK International Inc., Forte Research Systems, Inc., Bio-Optronics, Inc., PAREXEL International Corporation, Merge Healthcare Incorporated, ERT

SA

Clinical, Veeva Systems, Inc., and MedNet Solutions, Inc.

24

Table 6.

Global Clinical Trial Management Systems (CTMS) Market Snapshot

Global Clinical Trial Management Systems (CTMS) Market

2016

2022

1.32

2.95

Largest Segment, by Revenue –Software

Largest Segment, by Revenue – Pharmaceutical and Biotechnology Companies

PL

E

Fastest Growing Segment – Contract Research Organizations Largest Segment, by Revenue – Web-based

M

Fastest Growing Segment – Cloud-based Largest Segment, by Revenue – North America

SA

Country

Regions

Delivery Mode

End-users

Components

Total

Market Size (US$ billion)

Fastest Growing Segment – Asia-Pacific Largest Segment, by Revenue – U.S. Fastest Growing Segment – India

Source: Scalar Market Research Analysis

25

CAGR% (2016 – 2022)

14.3

3 MARKET DYNAMICS 3.1 Drivers Table 7.

Global Clinical Trial Management Systems (CTMS) Market Drivers 2014 – 16

Drivers

2017 – 19

2020 – 22

Increasing research and development expense in clinical research industries The research and development (R&D) wing of clinical research industry has remained capital intensive owing to its long development cycles. As the clinical industry is a researchintensive industry, majority of its activities are driven by the R&D funding.

SA

Source: Scalar Market Research Analysis Note:

● Very High Impact, ◕ High Impact, ◑ Medium Impact, ◔ Low Impact

26

●

E

M

PL

According to the Industrial Research Institute, the National Institutes of Health (NIH) possesses the second largest federal R&D budget of around $31.3 billion in 2016. The National Cancer Institute (NCI) possesses a research budget of over $5 billion in 2016. Also, the emerging countries such as China and India are providing robust funds in order to boost their clinical research industry.

◕

◑

3.2 Restraints Table 8.

Global Clinical Trial Management Systems (CTMS) Market Restraints Restraints

2014 – 16

Lack of efficient and skilled professionals to operate on hightech CTMS solutions There is a lack of qualified healthcare professionals owing to the under investment in healthcare sector. Also, there has been an increase in the emigration of healthcare personnel from their native states to high income countries. The health workers are discouraged owing to the poor working conditions, obsolete equipment, lack of professional development opportunities, and the absence of security measures

M

PL

● Very High Impact, ◕ High Impact, ◑ Medium Impact, ◔ Low Impact

SA

Note:

●

E

Source: Scalar Market Research Analysis

27

2017 – 19

●

2020 – 22

4.2 Ecosystem Analysis Figure 7. Clinical Trial Management Systems (CTMS) Market – Functional Process Map Study Idea

Study Design Protocol Development and Scientific Feasibility

Start Service Provider Operational Readiness

Study Design Phase (Language Must Harmonize / Operational Activities Must Synchronize)

Budget Development

Clinical Trial Agreement and/or Award

Complete Operational Readiness IRB Approval

E

Study Completion

Patient Management Phase

SA

Source: Scalar Market Research Analysis

Service Provider / Charge Generated

Payment Reconciliation

M

Study Close

PL

Study Close Out Phase

32

Schedule Services

Patient Screening / Enrolment / Registration

5 CLINICAL TRIAL MANAGEMENT SYSTEMS (CTMS) MARKET,

BY COMPONENTS The global clinical trial management systems (CTMS) market is expected to be valued at US$ XX billion in 2016. This market is expected to grow at a CAGR of XX% in the forecast period and reach US$ XX billion by 2022. The global clinical trial management systems (CTMS) market is bifurcated by components into software and service. The software is the largest market segment comprising of XX% share of the global clinical trial management systems (CTMS) market in 2016. Also, this market segment is expected to grow at the highest rate in the forecast period. The share of this market segment is expected to grow from XX% in 2016 to XX% in the 2022.

E

5.1.1 Global Clinical trial management systems (CTMS) Market Share (%), By Components, 2016 & 2022

PL

Figure 8. Global Clinical trial management systems (CTMS) Market Share (%), By Components, 2016 & 2022

2022

M

2016

21.3%

SA

6.1%

8.5%

Hardware

26.2%

Software

65.3% 72.5%

Service

Source: Scalar Market Research Analysis

The software market component segment dominated the clinical trial management systems (CTMS) market as it accounted for XX% of the market share in terms of revenue in 2015. This segment is expected to be valued at US$ XX billion in 2022.

Factors such as high popularity of cost-effective drugs in the biopharmaceutical industry, rising rate of adoption of CTMS owing to its various advantages and

33

increasing number of clinical trials is analyzed to propel the demand for software components during the forecast period. Also, the emergence of innovative drugs and intense competition among various pharmaceutical firms to complete the clinical trials and benefit from first to market strategy is expected to raise the demand for CTMS. Also, the software components segment is expected to be the fastest-growing segment during the forecast period. This segment is expected to grow at a CAGR of XX% between 2016 and 2022. Increasing government spending across the emerging economies of Asia-Pacific, Middle East & Africa, and Latin America, rising rate of adoption of CTMS solutions, enhanced product portfolio and increasing R&D expenditure of clinical research industry across the globe is analyzed to boost the

E

software segment during the forecast period.

Software Service Total

2014

2015

2016

M

Components

Global Clinical Trial Management Systems (CTMS) Market Size (US$ billion), By Components (2014 – 2022) 2017

2018

SA

Table 9.

PL

5.1.2 Global Clinical Trial Management Systems (CTMS) Market Size (US$ billion), By Components (2014 – 2022)

Source: Scalar Market Research Analysis

34

2019

2020

2021

2022

CAGR% (2016 – 2022)

5.1.3 Global Clinical Trial Management Systems (CTMS) Market Size (US$ billion), By Components, 2016 & 2022 Figure 9. Global Clinical Trial Management Systems (CTMS) Market Size (US$ billion), By Components, 2016 & 2022

US$ billion

2.20

0.97

0.75 0.35

Service

2022

PL

2016

E

Software

SA

M

Source: Scalar Market Research Analysis

35

5.2 Software 5.2.1 Global Clinical Trial Management Systems (CTMS) Software Market Size (US$ billion), By Regions (2014 – 2022) Table 10. Global Clinical Trial Management Systems (CTMS) Software Market Size (US$ billion), By Regions (2014 – 2022) Regions

2014

2015

2016

2017

2018

2019

2020

2021

North America Europe Asia-Pacific

E

Rest of the World

PL

Total

SA

M

Source: Scalar Market Research Analysis

36

2022

CAGR% (2016 – 2022)

5.3 Service 5.3.1 Global Clinical Trial Management Systems (CTMS) Service Market Size (US$ billion), By Regions (2014 – 2022) Table 11. Global Clinical Trial Management Systems (CTMS) Service Market Size (US$ billion), By Regions (2014 – 2022) Regions

2014

2015

2016

2017

2018

2019

2020

2021

North America Europe Asia-Pacific

E

Rest of the World Total

SA

M

PL

Source: Scalar Market Research Analysis

37

2022

CAGR% (2016 – 2022)

6 CLINICAL TRIAL MANAGEMENT SYSTEMS (CTMS) MARKET,

BY END-USERS The global Clinical trial management systems (CTMS) market is bifurcated by endusers into pharmaceutical and biotechnology companies, clinical research organizations,

and

medical

biotechnology

companies’

device

end-user

companies. segment

The

pharmaceutical

dominated

the

clinical

and trial

management systems (CTMS) market in 2015, as it accounted for XX% of the market share in terms of revenue. This segment is expected to be valued at US$ XX billion in 2022. The coupling of CTMS along with hospital information system (HIS) provides accurate and time-saving documentation during the process of drug formulation and thereby, simplifies the clinical trials. The major factors propelling the

E

growth of this market include vast research activities and innovation. There has been an increase in the research and development funds over the years and introduction

PL

of government-based clinical studies are expected to further spur the growth.

On the other hand, clinical research organizations end-user segment is expected to

M

be the fastest-growing segment during the forecast period. This segment is analyzed to grow at a CAGR of XX% between 2016 and 2022. Majority of the

SA

biopharmaceutical companies have become increasingly dependent on the contract research organizations (CRO) sector in order to provide research services across their research and development operations.

38

6.1.1 Global Clinical Trial Management Systems (CTMS) Market Share (%), By End-users, 2016 & 2022 Figure 10. Global Clinical Trial Management Systems (CTMS) Market Share (%), By End-users, 2016 & 2022

2.3% 1.2%

7.3%

Banking & Finance

2022

2016 7.5%

2.4% 1.2%

8.4%

8.7%

Commercial

9.1%

Education Government

8.1% 24.6%

18.4%

22.8%

15.9% 4.4%

Utilities & Energy

PL

Source: Scalar Market Research Analysis

Sports & Leisure Transportation

20.2%

E

4.8% 2.3%

16.6%

Manufacturing & Industrial Residential Retail

5.4% 5.3% 3.0%

Healthcare

M

6.1.2 Global Clinical Trial Management Systems (CTMS) Market Size (US$ billion), By End-users (2014 – 2022)

End-users Pharmaceutical and Biotechnology companies Clinical Research Organizations

SA

Table 12. Global Clinical Trial Management Systems (CTMS) Market Size (US$ billion), By End-users (2014 – 2022) 2014

2015

2016

2017

2018

Medical Device Companies Total Source: Scalar Market Research Analysis

39

2019

2020

2021

2022

CAGR% (2016 – 2022)

6.1.3 Global Clinical Trial Management Systems (CTMS) Market Size (US$ billion), By End-users, 2016 & 2022 Figure 11. Global Clinical Trial Management Systems (CTMS) Market Size (US$ billion), By End-users, 2016 & 2022

US$ billion

29.95

29.24

26.47 20.89

11.98

5.73

11.33

10.18

3.33

6.35 3.24

3.07 1.83

10.68 5.17

PL

E

4.60

15.13

2016

SA

M

Source: Scalar Market Research Analysis

40

2022

10.09 3.04 2.22

11.38 4.48

7 CLINICAL TRIAL MANAGEMENT SYSTEMS (CTMS) MARKET,

BY DELIVERY MODES The global clinical trial management systems (CTMS) market is bifurcated by delivery modes

into web-based, on-premise, and cloud-based mode. The web-

based delivery mode segment dominated the clinical trial management systems (CTMS) market in 2015, as it accounted for XX% of the market share in terms of revenue. This segment is expected to be valued at US$ XX billion in 2022. Factors such as enhancement of the clinical trial efficiency owing to the optimized process; centralized

database;

better

site

performance

by

augmented

investigator

relationships; reduced workload for research coordinators; efficiency in budgeting and financial management; and automated data processing and report generation

E

are propelling the market for web-based delivery mode market.

PL

On the other hand, cloud-based delivery mode segment is expected to be the fastest-growing segment during the forecast period. The segment is analyzed to grow at a CAGR of XX% between 2016 and 2022. The cloud-based solutions are

M

gaining huge popularity over the recent years. This technology leads to efficiency and cost-effectiveness in clinical data management, and it works well for both

SA

pharmaceutical companies as well as their CROs. The cloud-based infrastructure helps to have seamless experience as it streamlines data thereby improving its quality.

43

7.1.1 Global Clinical Trial Management Systems (CTMS) Market Share (%), By Delivery Mode, 2016 & 2022 Figure 12. Global Clinical Trial Management Systems (CTMS) Market Share (%), By Delivery Mode, 2016 & 2022 2022

2016

Web-based

20.3%

22.2%

On-premises 55.4%

56.0% 23.7%

22.5%

E

Cloud-based

PL

Source: Scalar Market Research Analysis

7.1.2 Global Clinical Trial Management Systems (CTMS) Market Size (US$ billion), By Delivery Mode (2014 – 2022)

Web-based On-premises

2014

2015

2016

2017

SA

End-users

M

Table 16. Global Clinical Trial Management Systems (CTMS) Market Size (US$ billion), By Delivery Mode (2014 – 2022) 2018

Cloud-based Total Source: Scalar Market Research Analysis

44

2019

2020

2021

2022

CAGR% (2016 – 2022)

7.1.3 Global Clinical Trial Management Systems (CTMS) Market Size (US$ billion), By Delivery Mode, 2016 & 2022 Figure 13. Global Clinical Trial Management Systems (CTMS) Market Size (US$ billion), By Delivery Mode, 2016 & 2022

US$ billion

1.63

0.74

0.65

0.66 0.31

On-premises 2022

PL

2016

Cloud-based

E

Web-based

0.27

SA

M

Source: Scalar Market Research Analysis

45

7.2 Web-Based Delivery Mode 7.2.1 Global Clinical Trial Management Systems (CTMS) Market Size (US$ billion) in Web-based Delivery Mode, By Regions (2014 – 2022) Table 17. Global Clinical Trial Management Systems (CTMS) Market Size (US$ billion) in Web-based Delivery Mode, By Regions (2014 – 2022) Regions

2014

2015

2016

2017

2018

2019

2020

2021

North America Europe Asia-Pacific

E

Rest of the World

PL

Total

SA

M

Source: Scalar Market Research Analysis

46

2022

CAGR% (2016 – 2022)

8 CLINICAL TRIAL MANAGEMENT SYSTEMS (CTMS) MARKET,

BY REGIONS The global clinical trial management systems (CTMS) market is segmented into regional segments of North America, Europe, Asia-Pacific (APAC), Middle East & Africa (MEA), and Latin America (LATAM). The clinical trial management systems (CTMS) market is a highly-fragmented market with numerous budding small-scale companies.

The North American region is a market leader in clinical trial management systems (CTMS) market and is estimated to continue its dominance over the forecast period owing to increasing number of clinical trials and growing rate of adoption of technology advanced CTMS in this region. As per the National Institute of Health

E

(NIH), in the year 2011, over 56,981 clinical trials were carried out in the U.S. alone.

Also, there is the presence and development of advanced IT infrastructure within this

PL

region that further boosts the market growth. Furthermore, the presence of by-laws such as Health Insurance Portability and Accountability Act (HIPPA) that help in the prevention of misuse & fraud, and entry of various new players is expected to

M

positively impact the market growth

SA

However, the Asia-Pacific is a fastest growing market and is projected to grow at a rate of XX% during the forecast period due to the presence of large patient base, presence of favorable regulatory guidelines, cost-effective clinical trials when compared to developed nations, and the rise of vast number of contract research organizations (CROs) in this region. Also, there has been a rise in the number of outsourced clinical trials in the Asia-Pacific region owing to the low-cost clinical trials facility that is set to further propel the growth of this market. The market is driven by other factors such as expanding enterprises, organizational pressures to limit costs, regulatory compliance, new technologies affecting a customer’s security operations, and security threats.

48

8.1 Segment Share Figure 14. Global Clinical Trial Management Systems (CTMS) Market Share (%), By Regions, 2016 and 2022 2022

2016 13.6%

North America

14.6% 31.1%

34.2%

Europe

21.7% Asia-Pacific

27.2%

27.1%

RoW

E

30.5%

PL

Source: Scalar Market Research Analysis

North America is analyzed to be the largest regional segment as it is valued at US$

M

XX billion in 2015. However, Asia-Pacific is expected to be the fastest-growing regional segment in the forecast period. This segment is expected to grow at a

SA

CAGR of XX% between 2016 and 2022 to account for US$ XX billion in 2022.

8.1.1 Global Clinical Trial Management Systems (CTMS) Market Size (US$ billion), By Regions (2014 – 2022) Table 20. Global Clinical Trial Management Systems (CTMS) Market Size (US$ billion), By Regions (2014 – 2022) Regions

2014

2015

2016

2017

2018

North America Europe Asia-Pacific Rest of the World Total Source: Scalar Market Research Analysis

49

2019

2020

2021

2022

CAGR% (2016 – 2022)

8.2 North America North America dominated the global clinical trial management systems (CTMS) market as it accounted for over XX% of the global market share in terms of revenue in 2015. The U.S. accounts for over XX% of North America’s market share in 2015.

The clinical trial management systems software market in the U.S. is the largest market globally in terms of revenues. This is owing to the presence of advanced and integrated IT infrastructure in this region.

8.2.1 North America Clinical Trial Management Systems (CTMS) Market Share (%), By Country, 2016 & 2022

E

Figure 16. North America Clinical Trial Management Systems (CTMS) Market Share (%), By Country, 2016 & 2022 2022

PL

2016 18.3%

19.9%

SA

M

U.S.

Rest of North America

80.1%

81.7%

Source: Scalar Market Research Analysis

The U.S. clinical trial management systems (CTMS) market is analyzed to be driven by rising number of clinical trials and increasing pharmaceutical research and development leading to development of innovative drugs. Majority of the clinical trials in the U.S. are funded by the National Institute of Health (NIH), academic groups, other government agencies, and voluntary health organizations. Thus, owing to increased governmental support and funding for the clinical research, the U.S. has become a preferred location for conducting clinical trials. The region is analyzed to grow at a CAGR of XX% during the forecast period.

51

8.2.2 North America Clinical Trial Management Systems (CTMS) Market Size (US$ billion), By Country (2014 – 2022) Table 21. North America Clinical Trial Management Systems (CTMS) Market Size (US$ billion), By Country (2014 – 2022) Country

2014

2015

2016

2017

2018

2019

2020

2021

2022

CAGR% (2016 – 2022)

U.S. Rest of North America Total

E

Source: Scalar Market Research Analysis

PL

8.2.3 North America Clinical Trial Management Systems (CTMS) Market Size (US$ billion), By Country, 2016 & 2022

M

Figure 17. North America Clinical Trial Management Systems (CTMS) Market Size (US$ billion), By Country, 2016 & 2022

SA

US$ billion

0.74

0.37

0.18 0.08

U.S.

Rest of North America 2016

Source: Scalar Market Research Analysis

52

2022

8.2.3.1 U.S. 8.2.3.1.1 Clinical Trial Management Systems (CTMS) Market in U.S., Market Size (US$ billion) and Y-o-Y Growth (%) Table 22. 8.2.3.1.1 Clinical Trial Management Systems (CTMS) Market in U.S., Market Size (US$ billion) and Y-o-Y Growth (%) Year

2014

2015

2016

2017

2018

2019

2020

2021

2022

CAGR% (2016 – 2022)

Market Size

Source: Scalar Market Research Analysis

E

8.2.3.2 Rest of North America

PL

8.2.3.2.1 Clinical Trial Management Systems (CTMS) Market in Rest of North America, Market Size (US$ billion) and Y-o-Y Growth (%)

Market Size

2014

2015

2016

2017

2018

SA

Year

M

Table 23. Clinical Trial Management Systems (CTMS) Market in Rest of North America, Market Size (US$ billion) and Y-o-Y Growth (%)

Source: Scalar Market Research Analysis

53

2019

2020

2021

2022

CAGR% (2016 – 2022)

8.2.4 North America Clinical Trial Management Systems (CTMS) Market Size (US$ billion), By Components (2014 – 2022) Table 24. North America Clinical Trial Management Systems (CTMS) Market Size (US$ billion), By Components (2014 – 2022) Components

2014

2015

2016

2017

2018

2019

2020

2021

2022

CAGR% (2016 – 2022)

Software Service Total Source: Scalar Market Research Analysis

PL

E

8.2.5 North America Clinical Trial Management Systems (CTMS) Market Size (US$ billion), By End-users (2014 – 2022) Table 25. North America Clinical Trial Management Systems (CTMS) Market Size (US$ billion), By End-users (2014 – 2022)

Medical Device Companies

2015

2016

2017

2018

M

Pharmaceutical and Biotechnology companies Clinical Research Organizations

2014

SA

End-users

Total Source: Scalar Market Research Analysis

54

2019

2020

2021

2022

CAGR% (2016 – 2022)

9 COMPETITIVE LANDSCAPE 9.1

Market Positioning of Key Players

The global clinical trial market systems (CTMS) market is dominated by Oracle Corporation and PAREXEL International Corporation. These vendors have historically commanded the highest share of the CTMS market. These vendors provide durable and comprehensive enterprise-class solutions. However, over the recent years, Medidata has brought various innovative approaches and solutions to the CTMS market. The approach adopted by Medidata includes cloud-based, modularized platform approach. This enables customers to procure accurately their requirements with novel integration with cloud-based EDC solution. The other major

E

vendors are also following Medidata by providing innovative incorporation with their

PL

private cloud deployment and EDC solutions options.

SA

Low

Medium

Geographic Reach

High

M

Figure 24. Market Positioning of Key Players

Low

Medium

Product

Oracle Corporation Medidata Solutions Bio-Optronics, Inc DATATRAK International, Inc DSG, Inc.

High PAREXEL International Corporation Merge Healthcare Incorporated ERT Clinical.

Forte Research Systems, Inc. Veeva Systems

Source: Annual Reports, Investor Presentations ,Primary Interviews and Scalar Market Research Analysis NOTE: Horizontal axis: Product Diversification, Vertical axis: Geographic Reach, Size of the Bubble: Market Developments

72

12 APPENDIX

12.1 Acronyms Table 50. List of Acronyms Acronym

Expansion Asia-Pacific

ACaaS

Access Control as a Service

CAGR

Compound Annual Growth Rate

CCTV

Closed-circuit Television

DIY

Do it Yourself

LATAM

Latin America

PSAP

Public Safety Answering Point

PSIM

Clinical Trial Management Systems (CTMS) Information Management

RFID

Radio-frequency Identification

VSaaS Y-o-Y

PL

M

SA

RoW

E

APAC

Rest of the World Video Surveillance as a Service Year on Year

Source: Scalar Market Research Analysis

93

12.2 Related Reports 

Population Health Management Market, by Delivery Mode (Cloud-based, On-Premise, Web-based), Component (Services, Software), End-User (Government Bodies, Healthcare Providers, Healthcare Payers, Employer Group) - Global Revenue, Trends, Growth, Share, Size and Forecast to 2022 Digital Health Market, by Services (Tele-Training, Tele-Monitoring, TeleEducation, Tele-Consultation), Technology (Telemedicine, Digitized Health Systems), Health Monitoring Wearable Devices (Sleep Sensors, Heart Rate Monitors, Activity Monitors, Continuous Glucose Monitors, Smart Watches,

M

PL

Growth, Share, Size and Forecast to 2022

E

Drug Delivery Devices, Wearable Patches) - Global Revenue, Trends,

SA



94